UNIZIMA

{
  "events": [
    {
      "kind": "capital_decrease",
      "after_eur": 5985818,
      "delta_eur": -1220652,
      "before_eur": 7206470,
      "contribution_type": null
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0744.643.759",
    "name_full": "UNIZIMA"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Inventures Investment Partners",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Soros Economic Development Fund",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Alerion BV",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Viva Finance SRL",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0744.643.759",
    "name_full": "UNIZIMA"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "auditor",
      "person": {
        "rrn": null,
        "name": "Deloitte R\u00E9viseur d\u0027Entreprises",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0744.643.759",
    "name_full": "Unizima"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 10781953.0,
      "delta_eur": 5000000.0,
      "before_eur": 5781953.0,
      "contribution_type": "geld"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0744.643.759",
    "name_full": "UNIZIMA"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 9060405.0,
      "delta_eur": 6000000.0,
      "before_eur": 3060405.0,
      "contribution_type": "geld"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0744.643.759",
    "name_full": "UNIZIMA"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "gestion journali\u00E8re",
      "person": {
        "rrn": null,
        "name": "Hala Audi",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0744.643.759",
    "name_full": "Unizima"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Udi Ronen",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Catherine Cax",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0744.643.759",
    "name_full": "UNIZIMA"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 6088736.0,
      "delta_eur": 1200000.0,
      "before_eur": 4888736.0,
      "contribution_type": "geld"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0744.643.759",
    "name_full": "UNIZIMA"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Innovation Fund",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0744.643.759",
    "name_full": "UNIZIMA"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "ANTROBUS",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0744.643.759",
    "name_full": "UNIZIMA"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Soros Economic Development Fund SA",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0744.643.759",
    "name_full": "UNIZIMA"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Inventures Investment Partner SA",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Innovation Fund",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0744.643.759",
    "name_full": "UNIZIMA"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 4888736,
      "delta_eur": 4827236,
      "before_eur": 61500,
      "contribution_type": "natura"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0744.643.759",
    "name_full": "AD Sanitas"
  }
}

{
  "stage": "proposal",
  "notary": {
    "name": "Sixtine Borres",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Charleroi",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2020-03-23",
    "filing_date": "2020-03-12",
    "act_kind_objet": "DEPOT D\u0027UN PROJET COMMUN D\u0027APPORT D\u0027UNE BRANCHE D\u0027ACTIVITE"
  },
  "decision": {
    "body": "raad_van_bestuur",
    "act_date": "2020-03-12",
    "unanimous": null
  },
  "conversion": null,
  "detected_kind": "branch_contribution",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0502.742.288",
        "name": "UNIVERCELLS",
        "role": "contributor",
        "address": "Rue Auguste Piccard 48, 6041 Charleroi",
        "is_foreign": false,
        "legal_form": "Soci\u00E9t\u00E9 anonyme",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      },
      {
        "kbo": "0744.643.759",
        "name": "AD SANITAS",
        "role": "recipient",
        "address": "Rue Auguste Piccard 48, 6041 Charleroi",
        "is_foreign": false,
        "legal_form": "Soci\u00E9t\u00E9 anonyme",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "12:93"
    ],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": null,
    "exchange_ratio_text": null,
    "new_shares_issued_n": null,
    "real_estate_included": false,
    "patrimony_description": "La branche d\u0027activit\u00E9 \u0027Biosimilaires\u0027 est transf\u00E9r\u00E9e de la soci\u00E9t\u00E9 UNIVERCELLS \u00E0 la soci\u00E9t\u00E9 AD SANITAS. Le transfert concerne une activit\u00E9 sp\u00E9cifique, sans transfert du patrimoine total de la soci\u00E9t\u00E9.",
    "equity_transferred_eur": null,
    "accounting_effective_date": null
  },
  "subject_company": {
    "kbo": "0744.643.759",
    "name_full": "AD SANITAS",
    "legal_form": "Soci\u00E9t\u00E9 anonyme"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Sixtine Borres",
    "org_rep_person_name": null
  },
  "summary_narrative": "Le conseil d\u0027administration de la soci\u00E9t\u00E9 anonyme UNIVERCELLS a d\u00E9cid\u00E9, le 12 mars 2020, de transf\u00E9rer sa branche d\u0027activit\u00E9 \u0027Biosimilaires\u0027 \u00E0 la soci\u00E9t\u00E9 anonyme AD SANITAS. Ce projet d\u0027apport est soumis \u00E0 d\u00E9p\u00F4t au greffe et \u00E0 publication au Moniteur belge conform\u00E9ment \u00E0 l\u0027article 12:93 du Code des soci\u00E9t\u00E9s et des associations.",
  "co_filed_documents": [],
  "detected_real_type": "branch_contribution",
  "referenced_correction": null,
  "should_reroute_to_category": null
}

{
  "notary": {
    "name": "G\u00E9rard INDEKEU",
    "firm_city": null,
    "firm_name": "G\u00E9rard INDEKEU - Dimitri CLEENEWERCK de CRAYENCOUR",
    "office_city": "Bruxelles",
    "is_associated": true
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2020-03-04",
    "filing_date": "2020-03-02",
    "act_kind_objet": "Objet de l\u0027acte:",
    "is_private_deed": false
  },
  "decision": {
    "body": "notarieel_alleen",
    "act_date": "2020-02-28",
    "unanimous": true
  },
  "founders": [
    {
      "org": {
        "kbo": "0502.742.288",
        "name": "UNIVERCELLS",
        "address": "Rue Auguste Piccard 48, 6041 Charleroi",
        "country": "BE",
        "legal_form": "SA",
        "foreign_register_name": null,
        "foreign_register_number": null
      },
      "kind": "rechtspersoon",
      "person": null,
      "share_class": null,
      "partner_role": "null",
      "contribution_type": "geld",
      "amount_paid_in_eur": 61500.0,
      "is_subscriber_only": false,
      "n_shares_subscribed": 61500,
      "amount_subscribed_eur": 61500.0,
      "is_anonymous_silent_partner": false
    }
  ],
  "voorwerp": {
    "full_text": "La soci\u00E9t\u00E9 a pour objet, en Belgique et \u00E0 l\u0027\u00E9tranger, soit directement, soit comme interm\u00E9diaire, tant pour son compte propre que pour le compte de tiers, sauf disposition contraire, ce qui est pr\u00E9vu ci-apr\u00E8s : Favoriser le d\u00E9veloppement de la recherche m\u00E9dicale et biom\u00E9dicale au sens large en vue d\u2019\u00E9laborer et concevoir des produits de toute nature incluant des m\u00E9dicaments ou des techniques m\u00E9dicales, en vue de favoriser tous services, savoir faires ou syst\u00E8mes techniques, sociologiques, philosophiques, psychologiques pouvant contribuer, de mani\u00E8re innovante, \u00E0 la sant\u00E9 et/ou au bien-\u00EAtre de l\u2019homme dans le respect de l\u2019environnement. L\u2019utilisation, la recherche, le d\u00E9veloppement en ce compris l\u2019organisation de tests cliniques, l\u2019exploitation, la transformation, le conditionnement, la fabrication, la promotion, l\u2019achat et la commercialisation sous toutes ses formes de tous produits chimiques ou biologiques, de tous s\u00E9rums, vaccins, toxines, biosimilaires et de tous produits, sous-produits ou d\u00E9riv\u00E9s d\u2019origine animale, v\u00E9g\u00E9tale, microbienne, pouvant servir sous une forme quelconque au diagnostic, \u00E0 la prophylaxie et \u00E0 la th\u00E9rapeutique des maladies humaines ou animales. La recherche et le d\u00E9veloppement, la promotion, l\u2019achat et la vente de tous produits pharmaceutiques, th\u00E9rapeutiques, cosm\u00E9tiques, di\u00E9t\u00E9tiques, \u00E0 usage humain, v\u00E9g\u00E9tal, animal, biologiques, produits chimiques, de tous mat\u00E9riels et instruments m\u00E9dicaux et chirurgicaux, et de mani\u00E8re g\u00E9n\u00E9rale, tous op\u00E9rations industrielles, commerciales, financi\u00E8res ou civiles se rapportant directement ou indirectement aux activit\u00E9s dans le domaine de l\u2019industrie biopharmaceutique. La soci\u00E9t\u00E9 peut r\u00E9aliser tous travaux et tout acte juridique qui sont de nature \u00E0 stimuler directement la r\u00E9alisation de son objet et notamment tout acte mobilier ou immobilier par rapport aux locaux m\u00E9dicaux, l\u2019achat et la vente du mat\u00E9riel m\u00E9dical et non-m\u00E9dical, le recrutement du personnel administratif ou soignant, en service dans la soci\u00E9t\u00E9. Elle ne peut cependant pas faire des actes qui sont contradictoires aux r\u00E8gles de la d\u00E9ontologie m\u00E9dicale. Elle peut constituer, d\u00E9velopper et g\u00E9rer un patrimoine mobilier et faire toutes op\u00E9rations mobili\u00E8res quelconques y compris celles se rapportant \u00E0 tous droits mobiliers comme l\u0027acquisition par voie d\u0027inscription ou de cession et la gestion d\u0027actions, de parts sociales, d\u0027obligations convertibles ou non, de pr\u00EAts de consommation, de pr\u00EAts ordinaires, de bons de caisse ou autres valeurs mobili\u00E8res, de quelque forme que ce soit, tant de personnes morales que d\u0027entreprises, belges ou \u00E9trang\u00E8res, existantes ou encore \u00E0 constituer. La soci\u00E9t\u00E9 pourra exercer tout mandat g\u00E9n\u00E9ralement quelconque ainsi que toute fonction autoris\u00E9e dans toute personne morale belge ou \u00E9trang\u00E8re en ce compris la fonction d\u2019administrateur, de d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re, de g\u00E9rant et de liquidateur. Ce mandat pourra \u00EAtre r\u00E9mun\u00E9r\u00E9 ou gratuit. La soci\u00E9t\u00E9 peut, par voie d\u0027apport en esp\u00E8ces ou en nature, de fusion, de souscription, de participation, d\u0027intervention financi\u00E8re ou autrement, prendre des participations dans d\u0027autres soci\u00E9t\u00E9s ou entreprises existantes ou \u00E0 cr\u00E9er, que ce soit en Belgique ou \u00E0 l\u0027\u00E9tranger, dont l\u0027objet serait semblable ou analogue au sien ou de nature \u00E0 favoriser son objet. Elle peut \u00E9galement consentir tous pr\u00EAts ou garantir tous pr\u00EAts consentis par des tiers, \u00E9tant entendu que la soci\u00E9t\u00E9 n\u0027effectuera aucune activit\u00E9 dont l\u2019exercice serait soumis \u00E0 des dispositions l\u00E9gales ou r\u00E9glementaires applicables aux \u00E9tablissements de cr\u00E9dits et/ou financiers. Elle peut faire toutes op\u00E9rations se rapportant directement ou indirectement au management en g\u00E9n\u00E9ral, et plus pr\u00E9cis\u00E9ment, sans que cette \u00E9num\u00E9ration ne soit limitative : la cr\u00E9ation de soci\u00E9t\u00E9s holding ou d\u0027exploitation, toutes activit\u00E9s d\u0027\u00E9tudes et de conseils, toutes prestations de services, tous travaux d\u0027administration, de gestion, tant aupr\u00E8s des entreprises que des particuliers. Elle peut octroyer des conseils et assister en toutes mati\u00E8res \u00E0 des entreprises et \u00E0 l\u2019administration et la gestion d\u2019entreprises. Elle peut faire toutes op\u00E9rations commerciales, industrielles et financi\u00E8res, immobili\u00E8res et mobili\u00E8res, se rapportant directement ou indirectement \u00E0 son objet ou susceptibles de favoriser son d\u00E9veloppement, \u00E0 l\u0027exception des op\u00E9rations sur valeurs mobili\u00E8res et immobili\u00E8res r\u00E9serv\u00E9es par la loi aux banques et aux soci\u00E9t\u00E9s de bourse. Elle peut constituer, d\u00E9velopper, promouvoir et g\u00E9rer un patrimoine immobilier, et r\u00E9aliser toute op\u00E9ration immobili\u00E8re et fonci\u00E8re quelconque, y compris celles se rapportant \u00E0 tous droits r\u00E9els immobiliers comme, entre autres, l\u0027emphyt\u00E9ose, la superficie ou encore le leasing immobilier, le tout dans son acceptation la plus large et notamment : l\u0027acquisition, l\u0027ali\u00E9nation, l\u0027acte de grever, l\u0027\u00E9change, la r\u00E9novation, la transformation, l\u0027am\u00E9nagement, l\u0027entretien, le lotissement, la prospection, l\u0027exploitation, la pr\u00E9paration pour construire, la locatio",
    "is_lucrative": true,
    "short_summary": "D\u00E9veloppement de la recherche m\u00E9dicale et biom\u00E9dicale, recherche, d\u00E9veloppement, commercialisation et gestion de produits pharmaceutiques, biologiques, cosm\u00E9tiques, di\u00E9t\u00E9tiques, mat\u00E9riel m\u00E9dical, ainsi que gestion de patrimoine immobilier et mobiliers."
  },
  "governance": {
    "organ_kind": "raad_van_bestuur",
    "n_directors_max": 0,
    "n_directors_min": 2,
    "representation_clause": "deux administrateurs conjointement ou un administrateur-d\u00E9l\u00E9gu\u00E9 seul",
    "co_signature_threshold_eur": null
  },
  "fiscal_year": {
    "end_mm_dd": "12-31",
    "start_mm_dd": "01-01",
    "first_exercise_end_date": "2020-12-31",
    "is_prolonged_first_exercise": false
  },
  "agm_schedule": {
    "time": "20:00",
    "month": 6,
    "rule_text": "troisi\u00E8me jeudi de juin"
  },
  "founding_event": {
    "n_shares_total": 61500,
    "n_share_classes": 1,
    "bank_attestation": null,
    "amount_paid_in_eur": 61500.0,
    "incorporation_date": "2020-02-28",
    "amount_subscribed_eur": 61500.0,
    "art_5_8_no_payment_due": false,
    "pre_incorporation_activity_from_date": "2020-02-28"
  },
  "subject_company": {
    "kbo": "0744.643.759",
    "email": null,
    "region": "waals_gewest",
    "website": null,
    "name_full": "AD SANITAS",
    "legal_form": "SA",
    "name_abbreviated": null,
    "zetel_address_raw": "Rue Auguste Piccard 48, 6041 Charleroi",
    "equity_account_type": "unavailable",
    "_kbo_filled_from_list": true
  },
  "initial_directors": [
    {
      "kind": "natural_person",
      "person": {
        "name": "Hugues BULTOT",
        "address": "Avenue de l\u0027Horizon 24, 1150 Woluwe-Saint-Pierre"
      },
      "via_org": null,
      "role_sub": "administrateur",
      "mandate_until": {
        "kind": "until_agm_year",
        "value": 2026
      },
      "rep_person_name": null,
      "additional_roles": [
        "administrateur-d\u00E9l\u00E9gu\u00E9"
      ],
      "bestuursverbod_checked": false,
      "bestuursverbod_check_date": null,
      "rep_prior_publication_ref": null
    },
    {
      "kind": "natural_person",
      "person": {
        "name": "Jos\u00E9 CASTILLO",
        "address": "Rue de la Buanderie 18 bo\u00EEte b3.1, 1000 Bruxelles"
      },
      "via_org": null,
      "role_sub": "administrateur",
      "mandate_until": {
        "kind": "until_agm_year",
        "value": 2026
      },
      "rep_person_name": null,
      "additional_roles": [
        "pr\u00E9sident du conseil d\u0027administration"
      ],
      "bestuursverbod_checked": false,
      "bestuursverbod_check_date": null,
      "rep_prior_publication_ref": null
    }
  ],
  "co_filed_documents": [
    "expedition",
    "statuten",
    "volmacht"
  ],
  "post_incorporation_mandates": [
    {
      "kind": "volmacht_kbo",
      "holder_org_kbo": null,
      "holder_org_name": "PwC Legal",
      "with_substitution": true,
      "holder_person_name": null
    }
  ]
}